[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

VIS et al., 2000 - Google Patents

Prognostic value of cell cycle proteins p27kip1 and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer

VIS et al., 2000

Document ID
2921698256944709395
Author
VIS A
NOORDZIJ M
FITOZ K
WILDHAGEN M
SCHRÖDER F
van der KWAST T
Publication year
Publication venue
The Journal of urology

External Links

Snippet

Purpose: Molecular tissue markers may give the clinician additional information about patients with prostate cancer at risk for treatment failure after retropubic radical prostatectomy. We substantiate the prognostic value of 3 tissue markers, the cell cycle …
Continue reading at www.auajournals.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
    • G06F17/30067—File systems; File servers

Similar Documents

Publication Publication Date Title
VIS et al. Prognostic value of cell cycle proteins p27kip1 and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer
YANG et al. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
Koh et al. A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results
D'AMICO et al. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer
Allaf et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer
Martins et al. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma
AMLING et al. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?
Theodorescu et al. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate
Grossklaus et al. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy
Brewster et al. Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy
Shariat et al. Critical review of prostate cancer predictive tools
Ohori et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer
Bader et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
Ray et al. E-cadherin protein expression predicts prostate cancer salvage radiotherapy outcomes
Uetsuki et al. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate
Freedland et al. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality
Chan et al. Prediction of pathological stage and clinical outcome in prostate cancer: an improved pre‐operative model incorporating biopsy‐determined intraductal carcinoma
Oefelein et al. Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate
Taftachi et al. Proliferating‐cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki‐67
Lee et al. The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy
Thomas et al. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage
Feuerstein et al. Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis
Saito et al. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically
Gettman et al. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma
Borre et al. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting